Request a quoteContact us
ABOUT LABBOT

Test the stability
as early as the biology.

Labbot Analytics builds the instruments that make it reasonable: they show a molecule's stability as conditions change.

OUR VISION

No drug should fail late for a stability problem that could have been seen early.

OUR MISSION

We make reliable stability data so easy to get that drug developers use it to guide their decisions, not just to confirm them.

Portrait of Marie-Louise Ainalem

Marie-Louise Ainalem

PhD
CEO AND CO-FOUNDER

Marie-Louise has spent more than 15 years where deep science meets commercial reality. She helped scale the European Spallation Source from a small core team to over 400 people, and has led go-to-market, financing and growth in regulated industries. PhD in physical chemistry, Lund University. As much at home with scientists as with investment committees.

Portrait of Thom Leiding

Thom Leiding

PhD
CTO AND CO-FOUNDER

Thom spent the first decades of his career as a software entrepreneur, scaling a company that still runs today. He then changed course and earned a PhD in biochemistry at Lund University. He invented the Labbot platform and has developed its hardware, software and predecessors for 15 years. At his best where technology, science and real applications meet.

Portrait of Maximilian Leiding

Maximilian Leiding

CMO AND CO-FOUNDER

Since his early teens, Maximilian has helped startups and small businesses launch new products through design, brand and marketing. As a founding member of Padelboard, he led UI/UX design and marketing through 100,000+ users and an acquisition by MATCHi. A designer by training, he brings the user’s perspective to marketing.

Portrait of Arne Nordström

Arne Nordström

CHAIR

Senior Advisor, Board Services at Lisberg Executive Search, and chair of Cryora Medical and TrackPaw Scientific. Previously CEO of Magle Life Sciences and Global Brand General Manager at Novartis Consumer Health, followed by more than 15 years in life science executive search.

Portrait of Eddie Thordarson

Eddie Thordarson

PhD
BOARD MEMBER

Venture Builder and Life Science Investments at LU Ventures. Previously COO at Guard Therapeutics, where he led a biologic drug from early preclinical work to the start of clinical development, and CEO of Magle. Earlier, he founded EsyTech and was product manager for Biotage’s microwave synthesis instruments. PhD in analytical chemistry, Lund University.